Status:
TERMINATED
Reproducibility and Method Comparison Studies of the Quo-Test™ A1C System and the Quo-Lab A1C Test and CLIA Waiver Study of the Quo-Test™ A1C System
Lead Sponsor:
Quotient Diagnostics Limited
Conditions:
Diabetes
Eligibility:
All Genders
18+ years
Brief Summary
The Quo-Test A1C Analyzer and Reagent Test System (Quo-Test A1C System) are intended for the in-vitro quantitative determination of glycated hemoglobin in whole blood samples obtained from fingerstick...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Aged 18 years or over
- Able to read English
- Read, understood and signed the Informed Consent Form
- Agrees to participate and does not withdraw\\
- Either healthy (without diabetes) or has Type 1 or Type 2 diabetes
- Exlcusion Criteria:
- • Declines participation or withdraws before study completion
Exclusion
Key Trial Info
Start Date :
April 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2014
Estimated Enrollment :
360 Patients enrolled
Trial Details
Trial ID
NCT01829061
Start Date
April 1 2013
End Date
April 1 2014
Last Update
March 29 2016
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
AMCR Institute
Escondido, California, United States, 92026
2
Ridgeview Research
Chaska, Minnesota, United States, 55318
3
University of Missouri
Columbia, Missouri, United States, 65212